Sponsored For
Beginners Choice

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
easyJet plc is an airlines business based in the UK. easyJet shares (EZJ) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. easyJet employs 14,000 staff and has a trailing 12-month revenue of around £3 billion.
Since the stock market crash in March caused by coronavirus, easyJet's share price has had significant negative movement.
Its last market close was £493.4, which is 67.29% down on its pre-crash value of £1508.5 and 20.34% up on the lowest point reached during the March crash when the shares fell as low as £410.
If you had bought £1,000 worth of easyJet shares at the start of February 2020, those shares would have been worth £360.44 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £341.09.
Latest market close | 493.4p |
---|---|
52-week range | 410p - 1512.6835p |
50-day moving average | 809.9882p |
200-day moving average | 647.4063p |
Wall St. target price | 1479.74p |
PE ratio | 11.9901 |
Dividend yield | 0.44p (8.39%) |
Earnings per share (TTM) | 61.2p |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the last close of 493.4p
1 week (2021-01-12) | -37.67% |
---|---|
1 month (2020-12-18) | -39.53% |
3 months (2020-10-19) | 493.4 |
6 months (2020-07-17) | -25.58% |
1 year (2020-01-17) | -66.61% |
---|---|
2 years (2019-01-18) | -57.90% |
3 years (2018-01-19) | -68.86% |
5 years (2016-01-19) | -69.77% |
Valuing easyJet stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of easyJet's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
easyJet's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, easyJet shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
easyJet's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.88. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into easyJet's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
easyJet's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £689 million.
The EBITDA is a measure of a easyJet's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | £3 billion |
---|---|
Gross profit TTM | £236 million |
Return on assets TTM | -5.84% |
Return on equity TTM | -44.19% |
Profit margin | -35.86% |
Book value | 4.175p |
Market capitalisation | £3.8 billion |
TTM: trailing 12 months
Steps to owning and managing Vaxart shares from Ireland.
Steps to owning and managing Takeda Pharmaceutical shares from Ireland.
Steps to owning and managing Sinovac Biotech Ltd shares from Ireland.
Steps to owning and managing Mesoblast shares from Ireland.
Steps to owning and managing Inovio Pharmaceuticals shares from Ireland.
Steps to owning and managing Heat Biologics shares from Ireland.
Steps to owning and managing CytoDyn shares from Ireland.
Steps to owning and managing Cynata Therapeutics shares from Ireland.
Steps to owning and managing BioNTech shares from Ireland.
Steps to owning and managing Atomo Diagnostics shares from Ireland.